Zydus has launched Ramelteon Tablets in the US upon receiving final approval from the USFDA

Zydus has launched Ramelteon Tablets in the US upon receiving final approval from the USFDA Ahmedabad, 24 July, 2019 Zydus Cadila announced the Day – 1 launch of Ramelteon Tablets (US RLD – Rozerem Tablets), 8 mg upon receiving the final approval from the USFDA. Ramelteon is a sedative, also called a hypnotic. It works by affecting certain substances in the body that help regulate the "sleep-wake cycle." Ramelteon is used to treat insomnia that is associated with having trouble falling asleep. The drug will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. The group now has 270 approvals and has so far filed over 360 ANDAs since the commencement of the filing process in FY 2003-04. About Zydus Cadila Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employs over 23,000 people worldwide and is dedicated to creating healthier communities globally. Zydus aspires to be a research-based pharmaceutical company by 2020. ***

The release as fetched from its publisher. zyduslife.com ↗